Arax Advisory Partners’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
Other funds holding AYTU
AIC
CAM
Arax Advisory Partners's AYTU Position: Q3 2026 in Review
Arax Advisory Partners held its AYTU BioPharma (AYTU) position steady in Q3 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5367.
Arax Advisory Partners first reported a position in AYTU in Q2 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold AYTU as of Q3 2026.
- Arax Advisory Partners held 2 shares of AYTU BioPharma worth $4 as of Q3 2026.
- Arax Advisory Partners left its AYTU BioPharma share count unchanged in Q3 2026.
- AYTU BioPharma made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #5367 holding.
- Arax Advisory Partners first reported a position in AYTU BioPharma in Q2 2026 and has held it in 2 quarters since.
- 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.